Sequoia Sciences is a pharmaceutical company discovering and developing new medicines targeting bacterial infections and cancers. Our pipeline includes a vaccine for the treatment and prevention of recurrent urinary tract infections, and compounds targeting infection and cancer. We also partner with academic and industry laboratories to elucidate the structures of natural products, biosynthetic intermediates, and unexpected synthetic products for pharmaceutical discovery.

 

Research & Development Pipeline

Vaccine for Recurrent Urinary Tract Infections

Ovarian & Lung Cancer